CG Oncology stock surges 27% in a month following superior efficacy data from its phase III study of cretostimogene for a bladder cancer indication.

In an eight-hour procedure at Ronald Reagan UCLA Medical Center, surgeons from UCLA Health and Keck Medicine of USC performed ...

Surgeons from Keck Medicine of USC and UCLA Health have performed the world's first-in-human bladder transplant. The surgery ...

AstraZeneca has announced positive high-level results from its Phase III POTOMAC trial assessing the efficacy of IMFINZI® ...

Dr. Daniel P. Petrylak discusses the different types of bladder cancer and how treatment options may vary based on disease ...

Dr. Daniel P. Petrylak sits down with CURE during Bladder Cancer Awareness Month to discuss key topics for patients with the ...

Investigators identify causative pathogens and risk factors for post-cystectomy UTI and associations with survival.

The approval in MIBC was based on positive results from the phase 3 NIAGARA trial, in which the Imfinzi regimen demonstrated ...

NMIBC is becoming more prominent as its incidence is correlated with older age groups, with the median age being 70 when ...

Bill Russell and Jim Rieker are survivors. Both diagnosed with bladder cancer, the men have made it their mission to help ...

You usually have a number of tests to find out if the symptoms you have could be due to bladder cancer. If you have bladder cancer, you then need more tests to find out how far it has grown. Your GP ...

ImmunityBio's ANKTIVA sBLA for papillary bladder cancer was rejected by the FDA despite prior support, prompting the company to request urgent talks.